Nasdaq
$1.04▼ 0.95%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $27.0MShares out 26.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
13- 9.29Regular26.09.30 01:22DEF 14AOther#●●●#●●●
ABVC BIOPHARMA, INC.
ABVC BioPharma will hold a special meeting of stockholders on October 28, 2026, to vote on the 2026 Equity Incentive Plan, ratification of previous equity awards, and the issuance of up to 1,600,653 shares of common stock for the acquisition of real estate in Taoyuan and Hualien, Taiwan. The proposed share issuance, intended to comply with Nasdaq listing rules, will be priced at no less than $1.00 per share.…more
$1.04-0.95%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.11After-hours26.09.12 05:30PRER14AOther
ABVC BIOPHARMA, INC.
ABVC BioPharma will hold a special meeting of stockholders on October 8, 2026, to vote on the approval of the 2026 Equity Incentive Plan, ratification of certain equity awards, and the issuance of up to 1,600,653 shares of common stock to acquire real estate in Taoyuan and Hualien, Taiwan. The shares are to be issued at a price of no less than $1.00 per share to comply with Nasdaq listing rules.…more
$1.04-0.95%vs prev closeView filingShare - 8.27Pre-market26.08.27 21:308-KKey event
ABVC BIOPHARMA, INC.
ABVC BioPharma completed the partial legal and structural separation of its subsidiary, BioKey (Cayman), on August 21, 2026. ABVC shareholders received 0.169464 ordinary shares of BioKey for each share held, leaving ABVC as the controlling shareholder with an 85% stake. BioKey is now an independent reporting entity and intends to apply for listing on the OTC Markets.…more
$1.04-0.95%vs prev closeView filingShare
12 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.